A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
for High Grade Osteosarcoma
Drug: Cabozantinib
174 locations incl. Birmingham
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: Up to 40
Code: NCT05691478·Phase 2, Phase 3·Recruiting